Kimbell Royalty Partners delivered a 30% YoY revenue increase, boosted its distribution by 15% to $0.47/unit. Read why KRP ...

GMO’s 13F portfolio jumps to ~$44B. See top holdings, key buys/sells, and rebalancing across tech, healthcare & ...

Sandisk Corporation is upgraded to a Strong Buy based on its AI-driven revenue surge, margin expansion and discounted ...

Micron Technology remains mispriced because of persistent memory scarcity, delayed supply additions, and accelerating AI ...

Nvidia Corporation retakes top U.S. market-cap spot as shares jump 15% YTD, driven by growth, Q2 beat and Vera Rubin traction ...

US soybean futures topped $13 per bushel for the first time since 2023 after the EPA’s revision of renewable fuel exemption ...

Perspective Therapeutics is rated Strong Buy on durable radiopharmaceutical data, $237M cash runway, and key 2026 catalysts.

PACS Group, Inc.’s Q2 revenue rose 9.1%, operating income grew 35.8%, and same-store occupancy reached 90.6%. Read more on ...

TDAQ is rated a Hold versus QQQ due to similar risk characteristics, a brief track record, and an expense ratio of 0.83%.

Netflix, Inc. stock looks undervalued with a strong moat and rising ad revenue. Click to learn NFLX's key risks, buy levels ...

Credo Technology Group is rated a Buy with robust AI infrastructure demand and attractive growth-to-valuation dynamics. Read ...

Lineage Cell Therapeutics is rated Hold due to its reliance on out-licensing and a risk-adjusted fair value below the current ...